Navigation Links
Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator
Date:9/4/2007

red among protocols. tcVisualize 3.0 can be configured to simulate multiple studies simultaneously so that stock can be shared at specified depots and even sites.

One of tcVisualize 3.0's many smaller enhancements is its new ability to model the usage of active pharmaceutical ingredients (or any other constituent element) in dispensing units, and to report consumption at both the dispensing unit and constituent level. This is the first step in a direction that is of great interest to the industry: a clinical manufacturing demand plan at the enterprise level, driven by reliable study models. Tourtellotte Solutions will be pursuing this aggressively in future releases of tcVisualize.

For more information about Tourtellotte Solutions and the tcVisualize(TM) 3.0 product, please call David Diamond at 1.866.653.2770 x103, or visit http://www.tourtellottesolutions.com.

About Tourtellotte Solutions

Tourtellotte Solutions is a global leader in off-the-shelf and custom supply-chain software for the pharmaceutical, retail, and consumer goods markets. Tourtellotte Solutions' tcVisualize(TM), a groundbreaking clinical supply chain modeling and forecasting application for the pharmaceutical industry, is used by several of the largest pharmaceuticals. Tourtellotte also sells RockBlocks(R), which is widely used for managing sourcing in the retail, consumer goods, branded apparel, and footwear industries. Tourtellotte Solutions is a privately-held company headquartered in Wayland, Massachusetts.

Contacts: Karen Adelman

KBA Folio Communications

1.508.655.2128

k.adelman@kbafolio.com


'/>"/>
SOURCE Tourtellotte Solutions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
2. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
3. Human Genome Sciences Reports Growing Evidence That Its TRAIL Receptor Antibodies Have Significant Potential in the Treatment of a Broad Range of Cancers
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
7. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
8. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
9. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
10. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
11. Critical Therapeutics Announces the Publication of Data for ZyfloCR (Zileuton) Extended-Release Tablets in the Journal of Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ... developing therapeutics that address unmet medical needs in ... Elston will present at the Marcum MicroCap ... , 4:00 PM EDTLocation: , The Grand Hyatt, ... www.juniperpharma.com, under  ,Investor, or  click here ...
(Date:5/26/2015)... 26, 2015  PAREXEL International Corporation (NASDAQ: PRXL ... the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  ... Officer, will be making a presentation on PAREXEL and ... June 9, 2015. A live webcast of ... of PAREXEL,s website at www.PAREXEL.com in the ...
(Date:5/26/2015)... 26, 2015  OrthoAccel ® Technologies, Inc., the leader ... growth accelerating in response to continued demand from orthodontists ... available in 2,500 practice locations in the U.S. and ... AcceleDent ® is the only FDA-cleared Class II ... orthodontic treatment by as much as 50 percent.  ...
Breaking Medicine Technology:Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2PAREXEL International To Present At Goldman Sachs Healthcare Conference 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3
... FARMINGDALE, N.Y., Nov. 2, 2011 Misonix, Inc. ... company that designs, manufactures, and markets innovative therapeutic ... cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical ... Ultrasonic Bone Cutting System and the SonaStar® Ultrasonic ...
... 2011 Perrigo Company (Nasdaq: PRGO ; TASE) ... Drug Administration (FDA) a New Drug Application (NDA) for testosterone ... the owner of the Reference Listed Drug of its filing. ... the United States District Court for the District of New ...
Cached Medicine Technology:Misonix Announces its Exhibition at the European Association of Neurosurgical Societies 2Misonix Announces its Exhibition at the European Association of Neurosurgical Societies 3Perrigo Confirms Filing for Testosterone Gel 1.0% and Announcement of Patent Infringement Lawsuit by Abbott 2
(Date:5/26/2015)... Abington is pleased to announce ... practice with seven medical professionals, has joined Abington ... site in the United States to be recognized ... the National Committee for Quality Assurance. , Family ... sick care – including routine gynecology care and ...
(Date:5/26/2015)... CA (PRWEB) May 26, 2015 Two ... recently joined Dr. Marissa Pei on a ... conversation focusing on addiction. Aired on KCAA AM 1050, ... Deena Duncan, marriage and family therapist, as they discuss ... estimated to affect more than 23.5 million Americans. The ...
(Date:5/26/2015)... 2015 CIO Review has chosen SIGNiX ... and Life Sciences Technology Solution Providers. The positioning is based ... solution which is applicable across the entire security spectrum of ... broad adoption. , “SIGNiX has been on our radar ... and Life Sciences Technology space, and we are happy to ...
(Date:5/26/2015)... National Prevention Week , National Prevention Week is ... by the Substance Abuse and Mental Health Services Administration ... action about, substance abuse as well as mental health ... to join in promoting prevention strategies, in educating other ... building community partnerships. , The Voice of One, the ...
(Date:5/26/2015)... Scientists at the University of Pennsylvania believe they ... patients benefit from immunotherapy; surgery may be the key. ... new research. Click here to read it now. ... and pulmonology theorized that, because large mesothelioma tumors have ... drugs might work better if the tumor size could ...
Breaking Medicine News(10 mins):Health News:Family Medicine, Geriatrics and Wellness Joins Abington Health Physicians 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 2Health News:Anaheim Lighthouse Staff Joined Dr. Marissa Pei’s in a Conversation on Drug and Alcohol Addiction 3Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 2Health News:CIO Review Selects SIGNiX as a 20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015 3Health News:Narconon Arrowhead Takes Part in National Prevention Week 2Health News:Narconon Arrowhead Takes Part in National Prevention Week 3Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2
... December 14, 2011 Elsevier, a world-leading provider of ... the Federation of Biochemical Societies (FEBS) announced today the ... access journal. The journal is dedicated to publishing articles ... health and disease. In launching this new journal, ...
... Valencia in Spain have analysed fresh orange juice squeezed ... 43% of samples exceeded the acceptable enterobacteriaceae levels laid ... handled correctly, that juicers are washed properly and that ... stored in metal jugs. ,Around 40% of the ...
... Matej Oreič from VTT Technical Research Centre of Finland ... signature indicative of hypoxia and up-regulated pentose phosphate pathway. ... assay from a serum sample months or even years ... a healthcare setting, the application of such an assay ...
... The two main ways to prevent and control influenza ... of investigators has found that statins, cholesterol-lowering drugs, may ... reduce mortality among patients hospitalized with influenza. The findings ... and are now available online. In an ...
... muscular dystrophy also have a higher risk of getting cancer, ... of the American Medical Association . The team found ... risk primarily for four types of cancer: brain, ovary, colon, ... also found a possible increased risk for some other types ...
... December 13, 2011 The American Cancer Society has ... transparency, consistency, and rigor in creating guidance about ... principles from the Institutes of Medicine (IOM) by ... guidelines, commissioning systematic evidence reviews, and clearly articulating ...
Cached Medicine News:Health News:Elsevier and Federation of Biochemical Societies launch new journal 2Health News:Microbial contamination found in orange juice squeezed in bars and restaurants 2Health News:Biochemical signature predicts progression to Alzheimer's disease 2Health News:Statins may reduce mortality in patients hospitalized with influenza 2Health News:Some muscular dystrophy patients at increased risk for cancer 2Health News:American Cancer Society revises cancer screening guideline process 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: